Woburn, MA, May 1, 2006 - BioTrove, Inc. announced today that Robert H. Ellis, Chairman, President, and Chief Executive Officer, will speak at Leerink Swann & Company's Emerging Life Science Tools Products and Applications Roundtable Discussion on May 9 in New York City.

Mr. Ellis will present a company overview that includes an update on the commercialization of BioTrove's two high throughput technology platforms: OpenArray™ SNP Genotyping for genomics research and RapidFire™ Lead Discovery for pharmaceutical screening.

A webcast of the presentation will be available from a link on BioTrove's website, www.biotrove.com. The live presentation will begin at about 11:45 am on May 9. The archived presentation will be available at 12:30 pm.

About BioTrove, Inc.

BioTrove offers two innovative platforms that dramatically increase the throughput of SNP genotyping and pharmaceutical screening.

The OpenArray™ platform enables genomics researchers to generate up to hundreds of thousands of parallel PCR reactions per day. The flexible format of the OpenArray™ plate allows researchers to adjust to their changing needs in sample and assay numbers. Additionally, the nanoliter scale of this flexible system makes high-throughput genotyping economical.

RapidFire™ Lead Discovery enables drug developers to analyze samples using ultra high-throughput mass spectrometry in less than 8 seconds per sample. This technology enables difficult targets (lipids, fatty acids, phospholipids, steroids, and prostaglandins) to be tested using a high-throughput, native detection method.

Robert Ellis
BioTrove, Inc.
781-721-3600
info@biotrove.com

Courtney Harris
Feinstein Kean Healthcare
617-761-6744
courtney.harris@fkhealth.com